| [1] |
Gurbel PA, Bliden KP, Butler K, et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of Ticagrelor versus Clopidogrel in patients with stable coronary artery disease[J]．Circulation.2009，120(25): 2577-2585.
|
| [2] |
Yundai Chen, Wei Dong, Zheng Wan，et al.Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome: A Pharmacodynamic Analysis[J]．Int J Cardiol. 2015，15；201：545-546.
|
| [3] |
Gurbel PA, Bliden KP, Butler K, et al.Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study[J]．Circulation.2010，16；121(10)：1188-1199.
|
| [4] |
Alexopoulos D1, Galati A, Xanthopoulou I，et al.Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study[J]．J Am Coll Cardiol.2012，17；60(3)：193-199.
|
| [5] |
李慕鹏，熊艳，陈小平．抗血小板药物替格瑞洛药代药效动力学及遗传药理学研究进展[J]．.中国临床药理学与治疗学.2014，19(2)：214-222.
|
| [6] |
Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes[J]．N Engl J Med.2009，361(11): 1045-1057.
|
| [7] |
Steg PG, James S, Harrington RA, et al. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis[J]．.Circulation. 2010，23；122(21)：2131-2141.
|
| [8] |
Matthijs A Velders, Jérémie Abtan, Dominick J Angiolillo，et al.Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention[J]．Heart.2016，102(8)：617-625.
|
| [9] |
Vercellino M, Sànchez FA, Boasi V，et al.Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction：1-year results by propensity score analysis[J]．BMC Cardiovasc Disord.2017，5；17(1)：97.
|
| [10] |
周登峰，石焱．氯吡格雷及替格瑞洛治疗急性冠状动脉综合征1年临床疗效对比[J]．中国临床医学.2016，23(3)：291-294.
|
| [11] |
许骥，华琦，胡少东，等．替格瑞洛在老年STEMI患者急诊PCI中的疗效与安全性分析[J]．首都医科大学学报，2015，36(1)：73-77.
|
| [12] |
阙斌，聂绍平，王春梅，等．替格瑞洛在老年心肌梗死急诊冠状动脉介入治疗中的作用研究[J]．中华老年心脑血管病杂志.2015，17(10)：1013-1016.
|
| [13] |
Yang J, Zeng P, Cai WY，et al.Comparison of treatment outcomes of ticagrelor and clopidogrel among patients undergoing percutaneous coronary intervention: A meta-analysis[J]．J Huazhong Univ Sci Technolog Med Sci.2017，37(5)：675-680.
|
| [14] |
Daniel Lindholm, Christoph Varenhorst, Christopher P Cannon，et al.Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial[J]．European Heart Journal.2014，35：2083-2093.
|
| [15] |
Cannon CP, Husted S, Harrington RA，et al.Safety，tolerability，and initial efficacy of AZD6140，the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndromes primary results of the DISPERSE2 trial[J]．J Am Coll Cardiol.2007，50(19)：1844-1851.
|
| [16] |
Bavishi C, Panwar S, Messerli FH，et al.Meta-Analysis of Comparison of the Newer Oral P2Y12 Inhibitors(Prasugrel or？Ticagrelor) to？Clopidogrel？in？Patients？With？Non-ST-Elevation Acute Coronary Syndrome[J]．Am J Cardiol. 2015，1；116(5)：809-17.
|
| [17] |
Alexopoulos D, Despotopoulos S, Xanthopoulou I，et al.Low-Dose Ticagrelor Versus Clopidogrel in Patients With Prior Myocardial Infarction[J]．J Am Coll Cardiol. 2017，70(16)：2091-2092.
|
| [18] |
Li P, Gu Y, Yang Y，et al.Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial[J]．Sci Rep.2016，6：31838.
|
| [19] |
Bonaca MP, Bhatt DL, Cohen M，et al.Long-term use of ticagrelor in patients with prior myocardial infarction[J]．N Engl J Med.2015 May 7；372(19)：1791-800.
|
| [20] |
Albert Yuh-Jer Shen, Janis F. Yao，Somjot S. Brar，et al.Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial Fibrillation.Journal of the American College of Cardiology[J]．J Am Coll Cardiol. 2007，50(4)：309-315.
|
| [21] |
Ma C．Current antithrombotic treatment in East Asia：some perspectives on anticoagulation and antiplatelet therapy[J]．Thromb Haemost.2012，107(6)：1014-1018.
|
| [22] |
《老年人心房颤动诊治中国专家建议》写作组，中华医学会老年医学分会，中华老年医学杂志编辑委员会．老年人非瓣膜性心房颤动诊治中国专家建议(2016)．中华老年医学杂志.2016，35(9)：915-928.
|
| [23] |
Young-Hoon Jeong. "East asian paradox" ：challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndrome[J]. Curr. Cardiol. Rep. 2014，16(5)：485.
|
| [24] |
Goto S, Toda E．Antiplatelet therapy after coronary intervention in Asia and Japan: the Asian perspective of antiplatelet intervention[J]. Hamostaseologie. 2009，29(4)：321-325.
|
| [25] |
Goto S, Huang CH, Park SJ，et al.Ticagrelor vs.clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome-- randomized，double-blind，phase III PHILO study[J]．Circ J．2015，75(11)：2452-2460.
|
| [26] |
Keun-Ho Park, Myung Ho Jeong b, Youngkeun Ahn，et al.Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization；from Korea Acute Myocardial Infarction Registry-National Institute of Health[J]．Int J Cardiol.2016，215：193-200.
|
| [27] |
Glenn N. Levine, Young-Hoon Jeong, Shinya Goto，et al.World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI.Glob Heart.2014，9(4)：457-67.
|
| [28] |
Bin Wu1, Houwen Lin, Ruoyan Gai Tobe，et al.Ticagrelor versus clopidogrel in East-Asian patients with acute coronary syndromes: a meta-analysis of randomized trials[J]．J Comp Eff Res.2017.
|
| [29] |
Caldeira D, Pinto FJ, Ferreira JJ.Dyspnea and reversibility profile of P2Y12 antagonists: systematic review of new antiplatelet drugs[J]. Am J Cardiovasc Drugs，2014，14(4)：303-311.
|
| [30] |
邵春丽，颜红兵，乔树宾，等．替格瑞洛相关呼吸困难的调查分析[J]．中国介入心脏病学杂志.2015，23(2)：85-88.
|
| [31] |
James S, Budaj A, Aylward P，et al.Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes(PLATO) trial[J]．Circulation，2010，122(11)：1056-1067.
|